| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/06/1999 | EP0947194A1 Dosage form comprising solid salts of R-alpha-lipoic acid with improved bioavailability |
| 10/06/1999 | EP0947193A2 Percutaneously applicable preparation and suppository containing an antidementia medicament |
| 10/06/1999 | EP0947192A1 Transparent antidandruff shampoos |
| 10/06/1999 | EP0946869A1 Channel mediating substrates |
| 10/06/1999 | EP0946733A1 Hsv/aav hybrid amplicon vectors |
| 10/06/1999 | EP0946724A2 POLYPEPTIDES OF THE "BASIC-HELIX-LOOP-HELIX" bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES |
| 10/06/1999 | EP0946721A1 Human growth gene and short stature gene region |
| 10/06/1999 | EP0946587A2 New amide compounds |
| 10/06/1999 | EP0946586A1 Aminosterol ester compounds |
| 10/06/1999 | EP0946585A1 Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them |
| 10/06/1999 | EP0946584A1 Meiosis regulating compounds |
| 10/06/1999 | EP0946580A1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 10/06/1999 | EP0946579A1 Novel erythromycin derivatives, method for preparing them and their use as medicine |
| 10/06/1999 | EP0946568A1 Use of 7-alkylidene cephalosporins to inhibit elastase activity |
| 10/06/1999 | EP0946567A1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them |
| 10/06/1999 | EP0946566A1 Pro-drugs and counterparts of camptothecin, their application as medicines |
| 10/06/1999 | EP0946564A1 New process for the preparation of morphinans |
| 10/06/1999 | EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS |
| 10/06/1999 | EP0946561A1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments |
| 10/06/1999 | EP0946558A1 Ethylidene derivatives of tricyclic carbapenems |
| 10/06/1999 | EP0946557A1 A-1-adenosine receptor antagonists |
| 10/06/1999 | EP0946555A1 Pyrrole derivatives, their preparation and pharmaceutical compositions containing them |
| 10/06/1999 | EP0946554A1 Fused bicyclic pyrimidine derivatives |
| 10/06/1999 | EP0946552A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 10/06/1999 | EP0946551A2 N-piperazin-1-ylphenyl-benzamide derivatives |
| 10/06/1999 | EP0946548A1 Novel heterocyclic substituted pyrrolidine amide derivatives |
| 10/06/1999 | EP0946547A1 A novel compound form |
| 10/06/1999 | EP0946546A1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine |
| 10/06/1999 | EP0946545A1 Novel carboxy substituted cyclic carboxamide derivatives |
| 10/06/1999 | EP0946542A1 Indane or dihydroindole derivatives |
| 10/06/1999 | EP0946541A1 Quinolines and their therapeutic use |
| 10/06/1999 | EP0946539A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 10/06/1999 | EP0946538A1 Indane or dihydroindole derivatives |
| 10/06/1999 | EP0946528A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 10/06/1999 | EP0946524A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists |
| 10/06/1999 | EP0946523A1 Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| 10/06/1999 | EP0946520A1 Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors |
| 10/06/1999 | EP0946519A1 Benzamide derivatives having a vasopressin antagonistic activity |
| 10/06/1999 | EP0946518A1 Modulators of proteins with phosphotyrosine recognition units |
| 10/06/1999 | EP0946517A1 N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application |
| 10/06/1999 | EP0946515A1 Parasiticidal pyrazoles |
| 10/06/1999 | EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 10/06/1999 | EP0946511A1 Novel compounds with analgesic effect |
| 10/06/1999 | EP0946510A1 Novel compounds with analgesic effect |
| 10/06/1999 | EP0946509A1 Novel heterocyclically substituted benzamides and their use in fighting diseases |
| 10/06/1999 | EP0946508A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 10/06/1999 | EP0946503A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 10/06/1999 | EP0946502A1 Sulfonamide interleukin-beta converting enzyme inhibitors |
| 10/06/1999 | EP0946501A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 10/06/1999 | EP0946499A1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 10/06/1999 | EP0946497A1 Process for the preparation of nmda antagonists |
| 10/06/1999 | EP0946495A1 Phenyl acetamides as spla2 inhibitors |
| 10/06/1999 | EP0946485A2 Method for treatment of dermatological disorders |
| 10/06/1999 | EP0946221A1 Combatting infection in delivery systems |
| 10/06/1999 | EP0946201A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation |
| 10/06/1999 | EP0946199A1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW |
| 10/06/1999 | EP0946197A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients |
| 10/06/1999 | EP0946190A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors |
| 10/06/1999 | EP0946188A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 10/06/1999 | EP0946185A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
| 10/06/1999 | EP0946184A2 Novel formulations for the administration of fluoxetine |
| 10/06/1999 | EP0946183A1 Methods of treating or preventing cardiac arrhythmia |
| 10/06/1999 | EP0946182A1 17$g(a)-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT |
| 10/06/1999 | EP0946181A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications |
| 10/06/1999 | EP0946180A1 Method for stimulating bone formation |
| 10/06/1999 | EP0946179A1 Method for treating autism |
| 10/06/1999 | EP0946178A1 Combination therapy for reducing the risks associated with cardiovascular disease |
| 10/06/1999 | EP0946177A1 METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A |
| 10/06/1999 | EP0946176A1 The use of 7-(2-oxa-5,8-diazabicyclo 4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of helicobacter pylori infections and associated gastroduodenal diseases |
| 10/06/1999 | EP0946175A1 USE OF AN H+, K+ -ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS |
| 10/06/1999 | EP0946174A1 Treatment of urinary incontinence and compositions for use therein |
| 10/06/1999 | EP0946173A1 Preparation of 3-fluoro oxindole derivatives |
| 10/06/1999 | EP0946172A1 Method for inhibiting stress-activated protein kinases |
| 10/06/1999 | EP0946171A1 Ophtalmic viscoelastic compositions |
| 10/06/1999 | EP0946170A1 Inhibition of protein glycation and prevention of vasculopathy |
| 10/06/1999 | EP0946168A1 Use of ethylene diamine disuccinate for preparing a medicament with antiviral properties |
| 10/06/1999 | EP0946167A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia |
| 10/06/1999 | EP0946166A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 10/06/1999 | EP0946165A1 Integrin antagonists |
| 10/06/1999 | EP0946164A1 Integrin antagonists |
| 10/06/1999 | EP0946163A2 Salts of acetaminophen |
| 10/06/1999 | EP0946162A1 Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases |
| 10/06/1999 | EP0946161A1 Sustained release pharmaceutical tablets with tramadol base and their preparation |
| 10/06/1999 | EP0946160A1 Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use |
| 10/06/1999 | EP0946159A1 An oil composition of dihydropolyprenols |
| 10/06/1999 | EP0946157A2 The topical use of kappa opioid agonists to treat ocular pain |
| 10/06/1999 | EP0946156A2 Therapeutic agents |
| 10/06/1999 | EP0946155A1 Pharmaceutical composition for treating fecal incontinence and anal itch |
| 10/06/1999 | EP0946151A1 Ascending-dose dosage form |
| 10/06/1999 | EP0946149A1 Homogeneous preformulations containing wigh concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations |
| 10/06/1999 | EP0946148A2 Non-ionic surfactant vesicles as a delivery agent for nucleic acid |
| 10/06/1999 | EP0946147A1 Treatment of equine laminitis |
| 10/06/1999 | EP0946146A2 New aqueous medicament preparations for the production of propellent gas-free aerosols |
| 10/06/1999 | EP0946145A2 Antitussive drugs delivered by ion exchange resins |
| 10/06/1999 | EP0946143A2 A nitroimidazole gel composition |
| 10/06/1999 | EP0946139A1 Pharmaceutical formulation |
| 10/06/1999 | EP0946099A1 Endoparasiticidal and ectoparasiticidal agents |
| 10/06/1999 | EP0946096A1 Nefazodone: use in treating post traumatic stress disorder |
| 10/06/1999 | EP0866693A4 Topically applied, structural cellulite treatments |
| 10/06/1999 | EP0839133B1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors |